GHRP-6
Sourcing GuideProcurement-quality evaluation of GHRP-6 centres on six markers: lot-specific COA availability, HPLC purity ≥98%, mass spec confirmation matching 873 Da, endotoxin testing for injectable routes, vendor regulatory disclosure, and cold-chain shipping options. Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP Stimulates GH release and concurrently increases hunger and gastric motility.. The QC discipline applies regardless of the application; sourcing standards do not relax for any particular use case.
Key Takeaways
Procurement lens: GHRP-6 sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching 873 Da. Mechanism: Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP. Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days. Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger). Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.
For procurement of GHRP-6, the relevant QC framework covers analytical purity (HPLC), structural identity (mass spec), microbiological safety (endotoxin), and stoichiometric correctness where applicable. Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP. Stimulates GH release and concurrently increases hunger and gastric motility. The subsections below address each QC layer and the vendor-tier landscape.
COA evaluation and red flags
Acceptable GHRP-6 certificates of analysis specify: (1) lot number matching the vial, (2) HPLC purity with chromatographic trace, (3) mass spec confirmation, (4) endotoxin testing for SubQ-route use, and (5) issuance from an accredited third-party laboratory. Template COAs that cannot be traced to a specific lot, COAs missing endotoxin data for injectable material, and COAs issued by the vendor's own laboratory rather than a third party are all sourcing red flags.
Reconstitution and storage protocols
GHRP-6 is typically supplied lyophilised in glass vials for reconstitution with bacteriostatic water. Standard reconstitution: dissolve at 1–2 mg/mL, store reconstituted material at 4°C, and use within 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Lyophilised storage at −20°C extends shelf life to 18–24 months for most peptides in this class.
Vendor tier comparison and price discipline
Three vendor tiers operate in the GHRP-6 market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.
Pharmaceutical-grade compounded GHRP-6 is the lowest-risk sourcing path for coa review use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
For users targeting lyophilisation quality, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
Sourcing GHRP-6 for vendor comparison use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
Pharmaceutical-grade compounded GHRP-6 is the lowest-risk sourcing path for storage protocol use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 100-300 mcg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 60-300 mcg | 4–6 weeks initial cycle |
| Sourcing Guide focus | SubQ | 100-300 mcg | 2-3x daily SubQ |
| Maintenance phase | SubQ | 70-300 mcg | Ongoing with periodic pauses |
Dose timing for GHRP-6 is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
GHRP-6 stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.
- GHRP-6 + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with GHRP-6's mechanism in sourcing / quality / procurement protocols.
- GHRP-6 + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with GHRP-6's mechanism in sourcing / quality / procurement protocols.
- GHRP-6 + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with GHRP-6's mechanism in sourcing / quality / procurement protocols.
- GHRP-6 + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with GHRP-6's mechanism in sourcing / quality / procurement protocols.
Marked appetite stimulation. Cortisol/prolactin elevation. Avoid if weight gain is undesirable.
Lens-specific safety considerations for sourcing / quality / procurement use of GHRP-6: Marked appetite stimulation. Cortisol/prolactin elevation. Avoid if weight gain is undesirable. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| GHRP-6 | Growth hormone releasing peptide | ~15-30 min | Sourcing Guide |
| BPC-157 | Stable gastric pentadecapeptide | ~4 hr (oral) | Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling |
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects |
| GHK-Cu | Tripeptide-copper complex | ~30 min plasma | A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression |
| Ipamorelin | Selective GHRP / ghrelin mimetic | ~2 hr | The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite |
What should I check on a GHRP-6 COA?
Storage protocol?
Lot variability across orders?
Pharmaceutical-grade versus research-grade?
What is the standard dosing protocol for GHRP-6?
How does GHRP-6's half-life affect dosing?
Start a GHRP-6 Protocol
Alukard provides GMP-certified physician-supervised sourcing with GMP-certified GHRP-6 and Pharmaceutical-grade compounds with full COA documentation.
Get ProtocolQuick Facts
- Molecular weight
- 873 Da
- Sequence length
- 6 aa
- Half-life
- ~15-30 min
- WADA
- Banned (S2)
- FDA
- Unapproved
Stack Partners
All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for GHRP-6 unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Sourcing / Quality / Procurement Protocol for GHRP-6
Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.
HIPAA Compliant · GMP Certified · Physician Supervised